Cargando…
Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants
Lipidic implants are valuable controlled delivery systems that present good biocompatibility and are useful for long-lasting therapies. However, these promising systems can present inflexible drug release profiles that limit their performance. Thus, finding new materials to overcome this drawback is...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401770/ https://www.ncbi.nlm.nih.gov/pubmed/34452124 http://dx.doi.org/10.3390/pharmaceutics13081163 |
_version_ | 1783745630020042752 |
---|---|
author | Júlio, Ana Sultane, Anaisa Viana, Ana Silveira Mota, Joana Portugal Santos de Almeida, Tânia |
author_facet | Júlio, Ana Sultane, Anaisa Viana, Ana Silveira Mota, Joana Portugal Santos de Almeida, Tânia |
author_sort | Júlio, Ana |
collection | PubMed |
description | Lipidic implants are valuable controlled delivery systems that present good biocompatibility and are useful for long-lasting therapies. However, these promising systems can present inflexible drug release profiles that limit their performance. Thus, finding new materials to overcome this drawback is crucial. Herein, lipidic implants containing caffeine and poorly soluble salicylic acid and rutin were developed. The inclusion of Gelucire(®) 50/02, sucrose, and two biobased ionic liquids, [Cho][Phe] and [Cho][Glu], were evaluated as a mean to improve the performance of the systems. The formulation procedure, dye content distribution, drug content, drug release, water content, and lipidic erosion of the developed systems were assessed. AFM analysis of the implants containing ILs was also performed. The results demonstrated that neither Gelucire(®) 50/02 nor sucrose were suitable tools to improve the drug release profile. In contrast, the ILs proved to be promising materials for multiple reasons; not only did they facilitate the formulation and incorporation of the studied drugs into the implants, but they also allowed a more suitable release profile, with [Cho][Glu] allowing a higher drug release due to its ability to increase surface wrinkling. Hence, this study showcases ILs as multitalented materials in lipid-based drug implants. |
format | Online Article Text |
id | pubmed-8401770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84017702021-08-29 Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants Júlio, Ana Sultane, Anaisa Viana, Ana Silveira Mota, Joana Portugal Santos de Almeida, Tânia Pharmaceutics Article Lipidic implants are valuable controlled delivery systems that present good biocompatibility and are useful for long-lasting therapies. However, these promising systems can present inflexible drug release profiles that limit their performance. Thus, finding new materials to overcome this drawback is crucial. Herein, lipidic implants containing caffeine and poorly soluble salicylic acid and rutin were developed. The inclusion of Gelucire(®) 50/02, sucrose, and two biobased ionic liquids, [Cho][Phe] and [Cho][Glu], were evaluated as a mean to improve the performance of the systems. The formulation procedure, dye content distribution, drug content, drug release, water content, and lipidic erosion of the developed systems were assessed. AFM analysis of the implants containing ILs was also performed. The results demonstrated that neither Gelucire(®) 50/02 nor sucrose were suitable tools to improve the drug release profile. In contrast, the ILs proved to be promising materials for multiple reasons; not only did they facilitate the formulation and incorporation of the studied drugs into the implants, but they also allowed a more suitable release profile, with [Cho][Glu] allowing a higher drug release due to its ability to increase surface wrinkling. Hence, this study showcases ILs as multitalented materials in lipid-based drug implants. MDPI 2021-07-28 /pmc/articles/PMC8401770/ /pubmed/34452124 http://dx.doi.org/10.3390/pharmaceutics13081163 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Júlio, Ana Sultane, Anaisa Viana, Ana Silveira Mota, Joana Portugal Santos de Almeida, Tânia Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants |
title | Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants |
title_full | Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants |
title_fullStr | Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants |
title_full_unstemmed | Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants |
title_short | Biobased Ionic Liquids as Multitalented Materials in Lipidic Drug Implants |
title_sort | biobased ionic liquids as multitalented materials in lipidic drug implants |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401770/ https://www.ncbi.nlm.nih.gov/pubmed/34452124 http://dx.doi.org/10.3390/pharmaceutics13081163 |
work_keys_str_mv | AT julioana biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants AT sultaneanaisa biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants AT vianaanasilveira biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants AT motajoanaportugal biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants AT santosdealmeidatania biobasedionicliquidsasmultitalentedmaterialsinlipidicdrugimplants |